Delivery Order 36C10G22D0004-36C10G22N0104
Award Date
9/26/22
Potential Completion Date
9/25/23
Potential Value
$325K
Federal Agency
Headquarters
Awardee
Tempus AI, Inc.
Ultimate Awardee
Not listed
NAICS Category
621511 - Medical Laboratories
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Fredericksburg, VA 22401, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for TUMOR NORMAL MATCHED GENOMIC TESTING SERVICES, awarded by the U.S. Department of Veterans Affairs (VA) to Tempus AI, Inc., doing business as Tempus Labs Inc. The contract has a ceiling value of $7,989,504.00 and is a firm fixed price delivery order with a performance period through January 27, 2024. Tempus Labs Inc. is the prime contractor and specializes in precision medicine and genomic sequencing services. The company has established itself as a key provider...
This federal contract award to Tempus AI, Inc. (doing business as Tempus Labs Inc.) is for tumor normal matched genomic testing services for the U.S. Department of Veterans Affairs (VA). The $5,718,045.00 firm fixed price delivery order contract, awarded on January 28, 2025, has a performance period extending through January 27, 2027. Tempus Labs Inc. is an experienced provider of genomic sequencing and precision medicine services to the VA, holding a larger $64,296,441.00 Indefinite Delivery...
Tempus Labs Inc. is providing tumor normal matched genomic testing services to the Department of Veterans Affairs (VA) under a $5,999,647 firm fixed price delivery order. This order was issued against an Indefinite Delivery contract held by Tempus with the VA worth up to $64 million for such services. Through January 2027, Tempus will analyze genomic sequencing data from veteran cancer patients' tumor and normal tissue samples to help inform precision medicine treatment decisions within the VA...
The Department of Veterans Affairs (VA) awarded a $2,022,406 Firm Fixed Price Delivery Order contract to Tempus Labs Inc., doing business as Tempus, to provide Tumor Normal Matched Genomic Testing Services. Tempus will perform genomic testing services on tumor and normal tissue samples from VA patients to identify genomic variants that may be targeted for precision cancer therapies. The contract has a one-year period of performance starting January 28, 2022 through January 27, 2023 and will be...
This is a firm fixed price delivery order contract awarded by the U.S. Department of Veterans Affairs Headquarters (VA HQ) to Akesogen, Inc.'s Tempus Labs division. The contract, valued at $10,477,738.83, tasks Tempus Labs with providing genomic sequencing, DNA quality assessment, single nucleotide polymorphism genotyping, methylation analysis, and other molecular testing services in support of the VA's biomedical research programs. The work is performed at the VA HQ in Washington, D.C. with...
This is a $4,000,000.00 firm fixed price delivery order contract awarded by the U.S. Department of Veterans Affairs Headquarters to Akesogen, Inc.'s Tempus Labs, Inc. division for genomic analysis services. The contract has a period of performance through July 21, 2025 and is not designated as a set-aside. Tempus Labs, a for-profit technology company, will provide genomic sequencing, DNA quality assessment, single nucleotide polymorphism genotyping, methylation analysis, and other molecular...
The Department of Veterans Affairs Headquarters awarded Akesogen, Inc. Tempus Labs, Inc. Division, a for-profit organization, a Firm Fixed Price Delivery Order contract worth $9,874,980.00 to provide genomic analysis services. The contract, with a performance period ending March 20, 2024, tasks Tempus Labs with conducting genomic sequencing, DNA quality assessment, single nucleotide polymorphism genotyping, methylation analysis, and other molecular testing services at the VA Headquarters in...
This firm fixed price purchase order contract was awarded by the Department of Veterans Affairs (VA) to Tempus AI, Inc. (Tempus Labs Inc.) to provide DNA methylation and genome-wide association services to evaluate changes in epigenetic aging for veterans with HIV who participated in a telehealth-delivered high-intensity exercise study. The contract has a ceiling value of $67,572.00 and a period of performance through September 29, 2025. There is no set-aside designation for this requirement....
This contract award to Akesogen, Inc.'s Tempus Labs, Inc. division is for genomic analysis services in support of the Department of Veterans Affairs (VA) Headquarters' biomedical research programs. The $440,000.00 firm fixed price delivery order contract, awarded on September 22, 2017, provides for genomic sequencing, single nucleotide polymorphism genotyping, methylation analysis, and other molecular testing services. This award is not associated with any set-aside designation. Akesogen, Inc....
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a $6,049,896.00 Firm Fixed Price Delivery Order contract to Akesogen, Inc. Tempus Labs, Inc. Division for genomic sequencing and analysis services. This contract, which does not have a set-aside designation, is in support of the VA's biomedical research programs, including the Million Veteran Program research initiative. Akesogen, Inc. Tempus Labs, Inc. Division has previously held delivery order contracts with the VA...